Long-term Safety and Antitumor Activity in the Phase 1–2 Study of Enzalutamide in Pre- and Post-docetaxel Castration-Resistant Prostate Cancer
Author:
Publisher
Elsevier BV
Subject
Urology
Reference7 articles.
1. Starving the addiction: new opportunities for durable suppression of AR signaling in prostate cancer;Knudsen;Clin Cancer Res,2009
2. Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth;Montgomery;Cancer Res,2008
3. Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis;Scher;J Clin Oncol,2005
4. Development of a second-generation antiandrogen for treatment of advanced prostate cancer;Tran;Science,2009
5. Increased survival with enzalutamide in prostate cancer after chemotherapy;Scher;N Engl J Med,2012
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synergistic Strategies for Castration-Resistant Prostate Cancer: Targeting AR-V7, Exploring Natural Compounds, and Optimizing FDA-Approved Therapies;Cancers;2024-08-06
2. Reasons for non-feasibility of therapeutic drug monitoring of oral targeted therapies in oncology – an analysis of the closed cohorts of a multicentre prospective study;British Journal of Cancer;2024-07-06
3. Experimental treatment efficacy of dmrFABP5 on prostate cancer singly or in combination with drugs in use;American Journal of Cancer Research;2024
4. Discovery of (2S)-N-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-3-(6-(4-cyanophenyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)-2-hydroxy-2-methylpropanamide as a Highly Potent and Selective Topical Androgen Receptor Antagonist for Androgenetic Alopecia Treatment;Journal of Medicinal Chemistry;2023-12-21
5. Novel androgen receptor inhibitors for metastatic hormone-sensitive prostate cancer: Current application and future perspectives;Biomedicine & Pharmacotherapy;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3